Assignee
MICROVAX LLC
US·18 granted patents·4 pending applications·28 citations·filing 2012–2023
Top patents by PatentIndex Score
22 records- 0191US8501707B2Mucin antigen vaccineMICROVAX LLC·Filed 2012·Granted Aug 6, 2013·8 cites·27 claims
- 0288US10046041B2Methods and compositions for suppressing virulence of methicillin resistant Staphylococcus aureusMICROVAX LLC·Filed 2016·Granted Aug 14, 2018·3 cites·12 claims
- 0388US8742087B2Mucin antigen vaccineMICROVAX LLC·Filed 2013·Granted Jun 3, 2014·4 cites·3 claims
- 0486US9757438B2Mucin antigen vaccineMICROVAX LLC·Filed 2016·Granted Sep 12, 2017·2 cites·6 claims
- 0583US9402920B2Mucin antigen vaccineMICROVAX LLC·Filed 2014·Granted Aug 2, 2016·2 cites·12 claims
- 0683US9353167B2Methods for generating immunity to antigenMICROVAX LLC·Filed 2014·Granted May 31, 2016·3 cites·5 claims
- 0782US11839655B2Combination cancer therapyMICROVAX LLC·Filed 2018·Granted Dec 12, 2023·1 cites·3 claims
- 0879US10183067B1TAA/CD4OL composition/vaccine for malariaMICROVAX LLC·Filed 2017·Granted Jan 22, 2019·1 cites·11 claims
- 0977US9642901B1TAA/CD40L vaccine for malariaMICROVAX LLC·Filed 2013·Granted May 9, 2017·1 cites·4 claims
- 1076US10166284B1Vaccines for herpes simplex virus 1 and 2MICROVAX LLC·Filed 2017·Granted Jan 1, 2019·1 cites·5 claims
- 1175US2024189422A1Combination cancer therapyMICROVAX LLC·Filed 2023·Application pending·0 cites
- 1272US9526774B1Methods and compositions for suppressing virulence of methicillin resistant Staphylococcus aureusMICROVAX LLC·Filed 2015·Granted Dec 27, 2016·1 cites·3 claims
- 1371US11097001B1Composition and method against tuberculosisMICROVAX LLC·Filed 2017·Granted Aug 24, 2021·1 cites·5 claims
- 1470US2022143171A1Cd40 ligand fusion protein vaccineMICROVAX LLC·Filed 2021·Application pending·0 cites
- 1564US2023241193A1mRNA VACCINE DESIGN USING MULTIPLE INTERACTING IMMUNO-STIMULATORY PATHWAYS, FOR CANCER AND INFECTIOUS DISEASESMICROVAX LLC·Filed 2023·Application pending·0 cites
- 1662US12427191B1SARS-CoV-2 fusion protein vaccine/regimenMICROVAX LLC·Filed 2022·Granted Sep 30, 2025·0 cites·15 claims
- 1755US11077183B2CD40 ligand fusion protein vaccineMICROVAX LLC·Filed 2016·Granted Aug 3, 2021·0 cites·17 claims
- 1850US11154603B1Burkholderia pseudomallei compositionMICROVAX LLC·Filed 2018·Granted Oct 26, 2021·0 cites·3 claims
- 1945US2013149330A1Pharmaceutical compositions and methods of blocking bacillus anthracisMICROVAX LLC·Filed 2013·Application pending·0 cites
- 2044US10174100B1Multivalent DNA composition for Yersinia pestisMICROVAX LLC·Filed 2015·Granted Jan 8, 2019·0 cites·8 claims
- 2140US10426827B1Dengue hemorrhagic fever virus vaccineMICROVAX LLC·Filed 2015·Granted Oct 1, 2019·0 cites·4 claims
- 2239US10293040B1Pharmaceutical compositions and methods of blocking Bacillus anthracisMICROVAX LLC·Filed 2015·Granted May 21, 2019·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when MICROVAX LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →